NEXTCURE, INC Shareholders' Equity
NEXTCURE, INC (NXTC) had Shareholders' Equity of $12.15 million as of 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-18
- 2026-06-30: Stockholders' Equity Attributable to Parent $12.15M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $26.72M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $34.94M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $23.65M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $12.15M S-4 · filed 2026-08-18 | |
| 2026-03-31 | $26.72M S-4 · filed 2026-08-18 | |
| 2025-12-31 | $34.94M S-4 · filed 2026-08-18 | |
| 2025-09-30 | $23.65M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $29.65M S-4 · filed 2026-08-18 | |
| 2025-03-31 | $55.85M S-4 · filed 2026-08-18 | |
| 2024-12-31 | $65.47M S-4 · filed 2026-08-18 | |
| 2024-09-30 | $75.59M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $85.44M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $99.05M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $114.42M S-4 · filed 2026-08-18 | |
| 2023-09-30 | $126.45M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $138.43M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $154.20M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $167.53M 10-K · filed 2025-03-06 | |
| 2022-09-30 | $181.54M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $198.20M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $213.94M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $233.39M 10-K · filed 2024-03-21 | |
| 2021-09-30 | $248.23M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $263.60M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $279.16M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $293.72M 10-K · filed 2023-03-02 | |
| 2020-09-30 | $307.34M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $321.92M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $331.76M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $321.48M 10-K · filed 2022-03-03 | |
| 2019-09-30 | $170.65M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $178.59M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | -$52.71M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | -$46.94M 10-K · filed 2021-03-04 | |
| 2018-09-30 | -$40.21M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$34.59M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | -$29.39M 10-Q · filed 2019-11-12 | -$29.38M 10-Q · filed 2019-06-10 |
| 2017-12-31 | -$24.41M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |